nivolumab,bempegaldesleukin
bms,nektar
['bempeg', 'opdivo', 'bristol', 'nektar']
esmo: adding bempeg to opdivo lowered response rate in bristol myers-nektar failed cancer trial - fiercebiotech #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #biotech #competitivemarketing 
Strategy & Competitive Marketing | Digital & Social Pharma | Life Sciences Investment | Cell & Gene Therapy | Vaccines